Diplomat Pharmacy (NYSE: DPLO) and HCA Holdings (NYSE:HCA) are both retail/wholesale companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, earnings, profitability, dividends, valuation and institutional ownership.
Institutional and Insider Ownership
66.5% of Diplomat Pharmacy shares are owned by institutional investors. Comparatively, 75.9% of HCA Holdings shares are owned by institutional investors. 30.2% of Diplomat Pharmacy shares are owned by company insiders. Comparatively, 2.9% of HCA Holdings shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Risk and Volatility
Diplomat Pharmacy has a beta of 0.74, suggesting that its share price is 26% less volatile than the S&P 500. Comparatively, HCA Holdings has a beta of 0.5, suggesting that its share price is 50% less volatile than the S&P 500.
This is a breakdown of recent ratings and price targets for Diplomat Pharmacy and HCA Holdings, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Diplomat Pharmacy presently has a consensus price target of $19.56, suggesting a potential downside of 1.20%. HCA Holdings has a consensus price target of $89.60, suggesting a potential upside of 15.30%. Given HCA Holdings’ stronger consensus rating and higher possible upside, analysts clearly believe HCA Holdings is more favorable than Diplomat Pharmacy.
Earnings and Valuation
This table compares Diplomat Pharmacy and HCA Holdings’ top-line revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||NetIncome||Earnings Per Share||Price/Earnings Ratio|
|Diplomat Pharmacy||$4.41 billion||0.31||$28.27 million||$0.10||198.00|
|HCA Holdings||$41.49 billion||0.66||$2.89 billion||$7.03||11.05|
HCA Holdings has higher revenue and earnings than Diplomat Pharmacy. HCA Holdings is trading at a lower price-to-earnings ratio than Diplomat Pharmacy, indicating that it is currently the more affordable of the two stocks.
This table compares Diplomat Pharmacy and HCA Holdings’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
HCA Holdings beats Diplomat Pharmacy on 10 of the 14 factors compared between the two stocks.
About Diplomat Pharmacy
Diplomat Pharmacy, Inc. (Diplomat) operates a specialty pharmacy business, which stocks, dispenses and distributes prescriptions for various biotechnology and specialty pharmaceutical manufacturers. The Company operates through specialty pharmacy services segment. The Company’s primary focus is on medication management programs for individuals with chronic diseases, including oncology, immunology, hepatitis, multiple sclerosis, specialty infusion therapy, and various other serious and/or long-term conditions. The Company provides specialty pharmacy support services to a national network of retailers and independent pharmacy groups, hospitals and health systems. The Company offers various services, such as specialty drug dispensing, retail specialty services, hospital and health system services, and hub services. The Company’s patient care system is used to coordinate and track patient adherence and safety.
About HCA Holdings
HCA Healthcare, Inc., formerly HCA Holdings, Inc., is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia. As of December 31, 2016, the American Group included 80 hospitals, which were located in Colorado, northern Georgia, Kansas, southern Kentucky, Louisiana, Mississippi, Missouri, Oklahoma, Tennessee and Texas. As of December 31, 2016, the Company operated six hospitals in England. The Company owns, manages or operates hospitals, freestanding surgery centers and freestanding emergency care facilities, walk-in clinics, diagnostic and imaging centers, among others.
Receive News & Ratings for Diplomat Pharmacy Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diplomat Pharmacy Inc. and related companies with MarketBeat.com's FREE daily email newsletter.